Skip to main content
Log in

Pharmacokinetics of sisomicin in normal patients and those with depressed renal function

Pharmakokinetik von Sisomicin bei Patienten mit normaler und eingeschränkter Nierenfunktion

  • II. Pharmakokinetik Und Klinische Pharmakologie
  • Published:
Infection Aims and scope Submit manuscript

Summary

The pharmacokinetics of sisomicin were studied in 29 patients and seven patients on chronic hemodialysis. The mean peak serum levels after intramuscular injection were 3.55 µg/ml at 0.5 hours. Levels of 1.5 µg/ml were present at six hours. The mean half-life of the drug varied with the renal function. In normal individuals the half-life is 1.85 hours. The apparent volume of distribution is 17.9 liters. 81% of a dose is recovered in the urine in a 12 hour period. Sisomicin is removed by hemodialysis with an average half-life of six hours and 39% removed during a six-hour dialysis period.

Zusammenfassung

Die Pharmakokinetik des Sisomicin wurde bei 29 Patienten und bei sieben Patienten mit chronischer Haemodialyse untersucht. Die mittleren Serumspitzenspiegel nach intramuskulärer Injektion betrugen 3,55 µg/ml nach 1/2 Std. Sechs Std. nach der Injektion waren noch 1,5 µg/ml vorhanden. Die mittlere Halbwertszeit des Antibiotikums war von der Nierenfunktion abhängig. Bei normaler Nierenfunktion beträgt die Halbwertszeit 1,85 Std. und das Verteilungsvolumen 17,9 Liter. 81 % der verabreichten Dosis werden während 12 Std. im Harn wiedergefunden. Durch die Haemodialyse wird Sisomicin mit einer durchschnittlichen Halbwertszeit von 6 Std. eliminiert und 39 % wurden während einer 6stündigen Dialyse ausgeschieden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature

  1. Bennet, J. V., Brodie, J. L., Benner, E. J., Kirby, W. M. M. Simplified accurate method for antibiotic assay of clinical specimens. Appl. Microbiol. 14 (1966) 170–177.

    Google Scholar 

  2. Dost, H. F. Grundlagen der Pharmakokinetik, S. 36, 238, 275, 292, 311. Thieme, Stuttgart 1968.

    Google Scholar 

  3. Regamey, C., Gordon, R. C., Kirby, W. M. M. Comparative pharmacokinetics of tobramycin and gentamicin. Clin. pharm. Therapeut. 14 (1973) 396–403.

    Google Scholar 

  4. Parry, M. F., Neu, H. C., Garvey, G. J., Ortiz-Neu, C., Appel, G. B.: Sisomicin therapy of serious gram-negative infections. Infection 4 (1976) Suppl. (in press).

  5. Rodriguez, V., Bodey, G. P. Valdivieso, M., Feld, R. Clinical pharmacology of sisomicin. Antimicrob. Ag. Chemother. 7 (1975) 38–41.

    Google Scholar 

  6. Lode, H., Kemmerich, B., Koeppe, P. Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin. Antimicrob. Ag. Chemother. 8 (1975) 396–401.

    Google Scholar 

  7. Jaffe, G., Meyers, B. R., Hirschman, S. Z. Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis and patients on chronic hemodialysis. Antimicrob. Ag. Chemother. 5 (1974) 611–616.

    Google Scholar 

  8. Welking, P. G., Mosegaard, A., Madsen, P. O. Sisomicin treatment of complicated urinary tract infections: Efficacy, tolerance and pharmacokinetics. J. clin. Pharm. 14 (1974) 567–573.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neu, H., Appel, G., Parry, M. et al. Pharmacokinetics of sisomicin in normal patients and those with depressed renal function. Infection 4 (Suppl 4), S403–S405 (1976). https://doi.org/10.1007/BF01646972

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01646972

Keywords

Navigation